Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schalling

Showing results (151-160 of 198) with videos related to

Pageof 20
Sort By:
American Journal of Hematology|May 26, 2017
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the diseaseGeorg Jeryczynski, Jürgen Thiele, Bettina Gisslinger, et al.
Blood|August 12, 2015
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia veraHeinz Gisslinger, Oleh Zagrijtschuk, Veronika Buxhofer-Ausch, et al.
Acta Neuropathologica|September 22, 2012
Localization of cholesterol, amyloid and glia in Alzheimer's disease transgenic mouse brain tissue using time-of-flight secondary ion mass spectrometry (ToF-SIMS) and immunofluorescence imagingSantiago Solé-Domènech, Peter Sjövall, Vladana Vukojević, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Translational Psychiatry|May 25, 2019
Genetic variant in SLC1A2 is associated with elevated anterior cingulate cortex glutamate and lifetime history of rapid cyclingMarin Veldic, Vincent Millischer, John D Port, et al.
American Journal of Hematology|December 30, 2014
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2bNicole C C Them, Klaudia Bagienski, Tiina Berg, et al.
Molecular Psychiatry|November 10, 2018
Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary reportEvelyn Andersson, James J Crowley, Nils Lindefors, et al.
Bipolar Disorders|November 4, 2015
Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorderMalik Nassan, Paul E Croarkin, Joan L Luby, et al.
Blood|May 9, 2019
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasmsFiorella Schischlik, Roland Jäger, Felix Rosebrock, et al.
Journal of Hepatology|April 24, 2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathySara Montagnese, Mette Lauridsen, Hendrik Vilstrup, et al.
Pageof 20

Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
American Journal of Hematology|May 26, 2017
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the diseaseGeorg Jeryczynski, Jürgen Thiele, Bettina Gisslinger, et al.
Blood|August 12, 2015
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia veraHeinz Gisslinger, Oleh Zagrijtschuk, Veronika Buxhofer-Ausch, et al.
Acta Neuropathologica|September 22, 2012
Localization of cholesterol, amyloid and glia in Alzheimer's disease transgenic mouse brain tissue using time-of-flight secondary ion mass spectrometry (ToF-SIMS) and immunofluorescence imagingSantiago Solé-Domènech, Peter Sjövall, Vladana Vukojević, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Translational Psychiatry|May 25, 2019
Genetic variant in SLC1A2 is associated with elevated anterior cingulate cortex glutamate and lifetime history of rapid cyclingMarin Veldic, Vincent Millischer, John D Port, et al.
American Journal of Hematology|December 30, 2014
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2bNicole C C Them, Klaudia Bagienski, Tiina Berg, et al.
Molecular Psychiatry|November 10, 2018
Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary reportEvelyn Andersson, James J Crowley, Nils Lindefors, et al.
Bipolar Disorders|November 4, 2015
Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorderMalik Nassan, Paul E Croarkin, Joan L Luby, et al.
Blood|May 9, 2019
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasmsFiorella Schischlik, Roland Jäger, Felix Rosebrock, et al.
Journal of Hepatology|April 24, 2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathySara Montagnese, Mette Lauridsen, Hendrik Vilstrup, et al.
Pageof 20